| JYSB2500046 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2025-02-26 | | Sanofi BV;Genzyme Ireland Ltd | | | view |
| JYSB2200061 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2022-03-30 | | Genzyme Ireland Ltd;Genzyme Europe BV | | | view |
| JYSB2101042 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2021-06-02 | | Genzyme Ireland Ltd;Genzyme Europe BV | | | view |
| JYSZ2300057 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | License Renew | 2023-12-28 | | Sanofi BV;Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd | | | view |
| JYSB2101043 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2021-06-02 | | Genzyme Ireland Ltd;Genzyme Europe BV | | | view |
| JYSZ2300056 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | License Renew | 2023-12-28 | | Sanofi BV;Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd | | | view |
| JYSB2500045 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2025-02-26 | | Sanofi BV;Genzyme Ireland Ltd | | | view |
| JYSB2200062 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2022-03-30 | | Genzyme Ireland Ltd;Genzyme Europe BV | | | view |
| JXSL0800014 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Import Drug Application | 2008-06-13 | Genzyme Corporation | Genzyme Corporation | Certificate Issued | 2009-05-27 | view |
| JYSB1200127 | 注射用阿加糖酶beta | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2012-05-23 | Genzyme Corporation | Genzyme Corporation;Hospira Inc | Certificate Issued | 2013-11-21 | view |
| JYSB1200128 | 注射用阿加糖酶beta | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2012-05-23 | Genzyme Corporation | Genzyme Corporation;Hospira Inc | Certificate Issued | 2013-11-21 | view |
| JXSL0800013 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Import Drug Application | 2008-06-18 | Genzyme Corporation | Genzyme Corporation | Certificate Issued | 2009-05-27 | view |
| JXSS1800022 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Import Drug Application | 2018-10-18 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV | Certificate Issued | 2019-12-23 | view |
| JYSB2000346 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2020-07-06 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV | Certificate Issued | 2020-10-27 | view |
| JYSB2000279 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2020-06-19 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV | Filed | 2020-06-22 | view |
| JYSB2000278 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2020-06-19 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV | Filed | 2020-06-22 | view |
| JYSB2000348 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Supplementary Application | 2020-07-06 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV | Certificate Issued | 2020-10-27 | view |
| JXSS1800021 | 注射用阿加糖酶β | agalsidase beta | Lyophilized | Biological Products | Import Drug Application | 2018-10-18 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV | Certificate Issued | 2019-12-23 | view |
